Department of Emergency, Intensive Care Medicine and Anesthesia, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.; Department of Anesthesiology and Intensive Care Medicine, Catholic University of the Sacred Heart, Fondazione 'Policlinico Universitario A. Gemelli' IRCCS, L.go F. Vito, 00168, Rome, Italy.
Dora Natalini studies ventilation techniques for patients who have both brain injuries and ARDS, a serious condition that causes severe breathing difficulties. Specifically, her research investigates how changing the devices used to deliver air can impact patient care. By comparing different methods, such as a heated humidifier versus a heat and moisture exchanger, she examines how these changes can decrease the amount of air delivered while still ensuring that patients receive the necessary support without negative effects on their brain blood flow.
Key findings
Switching from a heat and moisture exchanger (HME) to a heated humidifier (HH) allowed a reduction in tidal volume by 120 ml in brain-injured patients with ARDS.
Using the heated humidifier improved the management of breathing pressure for patients, indicating a safer ventilation approach.
The changes made by using the HH did not harm blood flow to the brain, suggesting better outcomes for brain-injured patients.
Frequently asked questions
Does Dr. Natalini study brain injuries?
Yes, Dr. Natalini specifically studies brain injuries in patients who also suffer from acute respiratory distress syndrome (ARDS).
What treatments has Dr. Natalini researched for ARDS?
She has researched the effectiveness of switching from heat and moisture exchangers to heated humidifiers in improving ventilation for ARDS patients with brain injuries.
Is Dr. Natalini's work relevant to patients with both brain injuries and ARDS?
Yes, her research is directly relevant to those patients, as it aims to improve their respiratory care and outcomes.
Publications in plain English
Early Platelet Dysfunction in Sepsis: An ICU Pilot Study.
2026
Pathogens (Basel, Switzerland)
Bocci MG, Sorrentino S, Gatto I, Natalini D, Cingolani E +11 more
Plain English This study looked at how platelets, which are important for blood clotting and fighting infections, behave in patients with sepsis, a severe infection. Researchers found that platelet dysfunction was already present when patients were admitted to the ICU, even before any significant drop in platelet count occurred. This early dysfunction was linked to the severity of the sepsis, with higher scores indicating worse conditions. Identifying these changes early may help doctors intervene sooner to improve treatment for septic patients.
Who this helps: This helps patients with sepsis and their doctors by enhancing early detection and treatment options.
The adaptor protein SKT interacts with PSD-95 and SHANK3 and affects synaptic functions.
2025
Cell reports
Morellato A, De Gregorio M, Angelini C, Torelli F, Belmonte V +27 more
Plain English This research focused on a protein called SKT and its role in brain cells where signals are transmitted, known as synapses. The study found that when SKT was removed in mice, it led to significant issues like reduced dendritic spines, which are crucial for communication between brain cells, and changes in behavior, such as increased grooming and poorer coordination. These findings highlight how important SKT is for proper brain function and how its loss can contribute to neurological problems, potentially linking it to conditions like autism.
Who this helps: This helps patients with neurological disorders and their doctors by providing insights into possible underlying mechanisms.
Viscoelastic Hemostatic Assays in the Management of Trauma-Induced Coagulopathy: A Clinical Update.
2025
Journal of clinical medicine
Natalini D, Xhemalaj R, Carelli S
Plain English This study looked at how new testing methods, called viscoelastic hemostatic assays (VHAs), can help manage a condition called trauma-induced coagulopathy (TIC), which affects blood clotting after injuries. The researchers found that VHAs can quickly assess various aspects of blood clotting, which allows doctors to tailor treatments more effectively. While these tests are increasingly recommended to help optimize blood transfusions, there is still disagreement about whether they actually improve patient outcomes compared to traditional testing methods.
Who this helps: This helps doctors and medical teams in emergency settings treat trauma patients more effectively.
Case report: First report ofandcoinfection in an immunocompromised patient.
2024
Frontiers in medicine
La Sorda M, Palucci I, Natalini D, Fillo S, Giordani F +13 more
Plain English This report describes the first known case of a patient with a weakened immune system being infected with both Legionnaires' disease and another infection. The patient likely caught the Legionnaires' infection from a hotel in Paris and might have gotten the second infection from a dog they were frequently in contact with. Understanding this case is important because it highlights the risks of coinfections in vulnerable individuals, which can complicate treatment and recovery.
Who this helps: This helps immunocompromised patients and their healthcare providers.
Advantages and drawbacks of helmet noninvasive support in acute respiratory failure.
2023
Expert review of respiratory medicine
Bongiovanni F, Michi T, Natalini D, Grieco DL, Antonelli M
Plain English This research looks at how using helmets for non-invasive ventilation (NIV) can help patients with severe breathing problems. The study found that while helmets might protect the lungs better and could potentially improve outcomes for some patients, specifically those with acute hypoxemic respiratory failure (AHRF), they did not show clear benefits over traditional face masks. For patients with chronic obstructive pulmonary disease (COPD), helmets may even be less effective than face masks and pose risks of rebreathing carbon dioxide.
Who this helps: This information benefits doctors treating patients with severe respiratory issues.
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response.
2023
Nature communications
Salemme V, Vedelago M, Sarcinella A, Moietta F, Piccolantonio A +28 more
Plain English The study focused on a protein called p140Cap and its role in breast cancer. Researchers found that p140Cap helps prevent the growth of tumor-initiating cells by inhibiting a protein called β-Catenin, which in turn reduces factors that promote an environment favorable for tumors. Clinical data showed that women with low levels of p140Cap had fewer immune cells fighting tumors and tended to have more aggressive cancers, suggesting that p140Cap could be an important marker for treatment strategies.
Who this helps: This helps breast cancer patients and doctors looking for better treatment options.
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity.
2023
Frontiers in oncology
Salemme V, Centonze G, Avalle L, Natalini D, Piccolantonio A +6 more
Plain English This study looked at how the area surrounding breast tumors (called the tumor microenvironment) affects the disease's behavior and resistance to treatment. Researchers found that differences in the types of cells within this environment can make breast cancer more or less responsive to therapies, highlighting the need to understand these interactions better. This is important because it can lead to more effective, personalized treatments for breast cancer patients.
Who this helps: Patients with breast cancer.
Bloodstream infections in COVID-19 patients undergoing extracorporeal membrane oxygenation in ICU: An observational cohort study.
2023
Heart & lung : the journal of critical care
Carelli S, Dell'Anna AM, Montini L, Bernardi G, Gozza M +11 more
Plain English This study looked at bloodstream infections in COVID-19 patients receiving a specific type of life support called ECMO in intensive care. Out of 68 patients, 44% developed bloodstream infections, with 32 infections occurring for every 1,000 days of ECMO treatment. Despite the high number of infections, there was no difference in overall survival rates between those with and without infections, and using antiviral drugs for COVID-19 helped reduce death rates in the ICU.
Who this helps: This information benefits doctors and healthcare providers treating critically ill COVID-19 patients.
p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.
2023
Cell death & disease
Centonze G, Natalini D, Grasso S, Morellato A, Salemme V +17 more
Plain English This study examined how a protein called p140Cap affects cancer cell movement and response to treatment in breast cancer. Researchers discovered that p140Cap helps increase cholesterol production in cancer cells, which is linked to reduced ability for cells to move and enhances sensitivity to treatments like statins. This finding is important because it may lead to better treatment strategies for breast cancer patients by identifying those who can benefit from specific therapies based on p140Cap levels.
Who this helps: Patients with breast cancer.
Comparison of the Asleep-Awake-Asleep Technique and Monitored Anesthesia Care During Awake Craniotomy: A Systematic Review and Meta-analysis.
2022
Journal of neurosurgical anesthesiology
Natalini D, Ganau M, Rosenkranz R, Petrinic T, Fitzgibbon K +2 more
Plain English This study compared two approaches used during awake craniotomy surgery: Monitored Anesthesia Care (MAC) and the Asleep-Awake-Asleep (SAS) technique. It found that MAC resulted in lower surgery failure rates (1% for MAC versus 4% for SAS) and shorter operation times (about 224 minutes for MAC compared to 328 minutes for SAS). However, SAS had fewer seizures during the procedure (10% for MAC versus 4% for SAS).
Who this helps: This information is valuable for patients undergoing awake craniotomy and their doctors.
Docking Protein p130Cas Regulates Acinar to Ductal Metaplasia During Pancreatic Adenocarcinoma Development and Pancreatitis.
2022
Gastroenterology
Costamagna A, Natalini D, Camacho Leal MDP, Simoni M, Gozzelino L +9 more
Plain English This study looked at a protein called p130Cas and its role in pancreatic cancer development, particularly how it helps cancer cells change from acinar cells to ductal cells. The researchers found that higher levels of p130Cas in cancer samples were linked to more aggressive tumors and poorer patient outcomes, while removing p130Cas in lab models significantly slowed tumor growth and increased survival by a median of 50%. This is important because it suggests that targeting the p130Cas and the related PI3K pathway could be a promising treatment strategy for some pancreatic cancer patients.
Who this helps: Patients with pancreatic cancer and their doctors.
Hemodynamic response to positive end-expiratory pressure and prone position in COVID-19 ARDS.
2022
Respiratory physiology & neurobiology
Dell'Anna AM, Carelli S, Cicetti M, Stella C, Bongiovanni F +7 more
Plain English This study looked at how two treatments—high positive end-expiratory pressure (PEEP) and lying face down (prone position)—affect blood flow and oxygen levels in patients with severe respiratory issues caused by COVID-19. The researchers found that using high PEEP improved oxygen levels in all nine patients and reduced blood flow problems caused by the lungs, but it also decreased heart output by 18%. On the other hand, lying in a prone position significantly improved oxygen levels without harming heart function.
Who this helps: This benefits patients with severe COVID-19 respiratory failure and their doctors.
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression.
2022
Cellular and molecular life sciences : CMLS
Quirico L, Orso F, Cucinelli S, Paradzik M, Natalini D +8 more
Plain English This paper studies how certain tiny molecules called microRNAs (miRNAs) influence how cancer cells use sugar and amino acids, which in turn affects their ability to stick together and move. The researchers found that changes in specific miRNAs can disrupt the normal energy processes in these cells, leading to increased movement and spread of tumors. Understanding this connection is important because it could help us figure out new ways to stop cancer from spreading.
Who this helps: This research benefits doctors and cancer patients by providing potential targets for new treatments to prevent tumor growth and spread.
Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression.
2022
Frontiers in oncology
Centonze G, Natalini D, Piccolantonio A, Salemme V, Morellato A +3 more
Plain English This research looks at how cholesterol and its forms affect the growth and spread of breast cancer. It found that high cholesterol levels can make cancer cells more aggressive and reduce the effectiveness of chemotherapy by blocking drug entry into these cells. Lower levels of vitamin D are linked to a higher risk of breast cancer, while certain hormones can fuel cancer progression. Understanding these relationships could help improve treatment options for breast cancer patients.
Who this helps: Patients fighting breast cancer.
High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial.
2022
American journal of respiratory and critical care medicine
Maggiore SM, Jaber S, Grieco DL, Mancebo J, Zakynthinos S +21 more
Plain English This study compared two types of oxygen therapy—high-flow nasal oxygen and VenturiMask—after patients with low blood oxygen levels were taken off a ventilator. Among nearly 500 patients, 13% who received high-flow oxygen needed to be reintubated within 72 hours, compared to 11% who received the VenturiMask. However, high-flow oxygen was associated with a lower need for additional breathing support: 8% of the high-flow group required this rescue treatment compared to 17% of the VenturiMask group within 72 hours.
Who this helps: This benefits patients recovering from severe respiratory issues who may need oxygen therapy after being on a ventilator.
p140Cap Regulates the Composition and Localization of the NMDAR Complex in Synaptic Lipid Rafts.
2022
The Journal of neuroscience : the official journal of the Society for Neuroscience
Angelini C, Morellato A, Alfieri A, Pavinato L, Cravero T +13 more
Plain English This research focused on a protein called p140Cap and its role in regulating a key receptor in the brain, known as NMDAR, which is important for learning and memory. The study found that in mice lacking p140Cap, the NMDAR subunit GluN2A had poorer connections with another important protein, PSD95, which can disrupt normal brain signaling. This is significant because it sheds light on how disruptions in these proteins may contribute to neurological and psychiatric disorders.
Who this helps: This helps patients with neurological and psychiatric conditions, as understanding these mechanisms could lead to better treatments.
Helmet noninvasive support for acute hypoxemic respiratory failure: rationale, mechanism of action and bedside application.
2022
Annals of intensive care
Cesarano M, Grieco DL, Michi T, Munshi L, Menga LS +11 more
Plain English Researchers studied the use of helmet noninvasive support for patients experiencing severe low oxygen levels in the blood (hypoxemia) to see if it offered advantages over other oxygen delivery methods. They found that using a helmet can effectively deliver higher levels of pressure support comfortably for patients, possibly improving breathing and reducing the necessity for intubation, with a positive end-expiratory pressure ranging from 10-15 cmH2O. This matters because it may lead to better oxygenation and protection against lung injury for patients struggling to breathe without the need for more invasive procedures.
Who this helps: This helps patients with acute respiratory failure and healthcare providers managing their care.
SARS-CoV-2-The Role of Natural Immunity: A Narrative Review.
2022
Journal of clinical medicine
Diani S, Leonardi E, Cavezzi A, Ferrari S, Iacono O +8 more
Plain English This review looked at how natural immunity from recovering from COVID-19 compares to vaccine-induced immunity in protecting against the virus. It found that most people who recover from COVID-19 develop a strong and lasting immunity, which is often better than the short-term immunity from vaccines. Specifically, reinfections tend to have milder symptoms, with hospitalization rates around 0.06% and very low death rates, indicating that the body's natural defense mechanisms are highly effective.
Who this helps: Patients who have recovered from COVID-19 may find they have strong immunity and might not need vaccination.
Plain English This study looked at how controlling body temperature after someone has a cardiac arrest affects survival and brain function. It reviewed past research, including a large study with 1,900 patients, and found no significant benefits from cooling patients to a lower temperature (33°C) compared to keeping them at a normal temperature or just preventing fever. This finding is important because it suggests that doctors should focus on monitoring temperature and preventing fever rather than trying to cool patients down after resuscitation.
Who this helps: This helps doctors and healthcare providers caring for patients recovering from cardiac arrest.
The p140Cap adaptor protein as a molecular hub to block cancer aggressiveness.
2021
Cellular and molecular life sciences : CMLS
Salemme V, Angelini C, Chapelle J, Centonze G, Natalini D +5 more
Plain English This study examined the p140Cap protein, which is linked to certain cancers like breast cancer and neuroblastoma. Researchers found that higher levels of p140Cap in tumors are associated with better survival rates; for example, patients with ERBB2-positive breast cancer fared better when p140Cap levels were high. Understanding how p140Cap influences cancer growth and spread can help doctors identify which patients might benefit from specific treatments.
Who this helps: This helps patients with breast cancer and neuroblastoma by identifying potential markers for better treatment outcomes.
High Failure Rate of Noninvasive Oxygenation Strategies in Critically Ill Subjects With Acute Hypoxemic Respiratory Failure Due to COVID-19.
2021
Respiratory care
Menga LS, Cese LD, Bongiovanni F, Lombardi G, Michi T +19 more
Plain English This study looked at how well noninvasive oxygen treatments helped critically ill COVID-19 patients in the ICU who were struggling to breathe. Out of 85 patients, 61% needed to be put on a ventilator after starting these treatments, which is a high failure rate compared to patients with other causes of breathing problems (59% for COVID-19 versus 35% for other causes). This matters because it shows that COVID-19 patients have a much higher chance of these treatments failing, especially those with a specific combination of health indicators.
Who this helps: This information helps doctors care for COVID-19 patients by identifying those at higher risk for treatment failure.
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial.
2021
JAMA
Grieco DL, Menga LS, Cesarano M, Rosà T, Spadaro S +25 more
Plain English This study looked at how well helmet noninvasive ventilation works compared to high-flow nasal oxygen for COVID-19 patients experiencing moderate to severe breathing difficulties. Researchers found that both treatments allowed patients to be free from respiratory support for a similar number of days, with 20 days for the helmet group and 18 days for the high-flow group, which is not a significant difference. However, patients using the helmet were less likely to need intubation (30% vs. 51%) and managed to avoid invasive mechanical ventilation for an average of 3 additional days.
Who this helps: This benefits patients with COVID-19 who have significant breathing problems, as well as their healthcare providers.
p130Cas/and p140Cap/Adaptors: The Yin Yang in Breast Cancer?
2021
Frontiers in cell and developmental biology
Centonze G, Natalini D, Salemme V, Costamagna A, Cabodi S +1 more
Plain English This study looked at two proteins, p130Cas and p140Cap, and their roles in breast cancer. Researchers found that high levels of p130Cas are linked to more aggressive tumors, while p140Cap appears to help suppress tumor growth, meaning that higher amounts of p140Cap correlate with slower tumor progression. Understanding these proteins matters because they could offer new ways to predict how aggressive a breast cancer might be and potentially guide future treatments.
Who this helps: Patients with breast cancer and their doctors.
Tidal Volume Lowering by Instrumental Dead Space Reduction in Brain-Injured ARDS Patients: Effects on Respiratory Mechanics, Gas Exchange, and Cerebral Hemodynamics.
Plain English This study looked at how switching from a heat and moisture exchanger (HME) to a heated humidifier (HH) could help lower the amount of air (tidal volume) given to brain-injured patients with acute respiratory distress syndrome (ARDS). Researchers found that using the HH allowed a reduction in tidal volume by 120 ml and helped improve the management of breathing pressure without harming blood flow to the brain. This matters because it shows a safer way to ventilate patients with both brain injuries and ARDS, potentially leading to better outcomes.
Who this helps: This helps brain-injured patients suffering from ARDS and their doctors.
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study.
2020
European review for medical and pharmacological sciences
Bocci MG, Maviglia R, Consalvo LM, Grieco DL, Montini L +12 more
Plain English This study looked at how blood clotting works in COVID-19 patients who were severely ill and in the ICU, focusing on those with acute respiratory distress syndrome (ARDS). Researchers found that these patients had high levels of certain proteins involved in blood clotting, specifically elevated fibrinogen and D-dimer levels, which indicate an increased risk of abnormal clotting. Even after a week of receiving standard anticoagulant treatment, their clotting patterns did not improve, showing that the treatment did not address these issues effectively.
Who this helps: This information is useful for doctors treating COVID-19 patients, as it highlights the need for better management of blood clotting in these individuals.
The N-terminal domain of the adaptor protein p140Cap interacts with Tiam1 and controls Tiam1/Rac1 axis.
2020
American journal of cancer research
Chapelle J, Baudino A, Torelli F, Savino A, Morellato A +9 more
Plain English This research focused on a protein called p140Cap and its connection to breast cancer progression, particularly in Her2-positive cases. The study found that high levels of p140Cap are linked to better survival rates in patients, as it appears to limit cancer spread by interacting with another protein, Tiam1, reducing its activity. Specifically, in one group of patients, higher p140Cap levels correlated with significantly increased survival probabilities.
Who this helps: Patients with Her2-positive breast cancer can benefit from understanding the role of p140Cap in their condition.
Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
2019
Scientific reports
Costamagna A, Rossi Sebastiano M, Natalini D, Simoni M, Valabrega G +6 more
Plain English This study focused on the interaction between two proteins, ErbB2 and p130Cas, which are important in about 15-20% of breast cancers. The researchers found that the connection between these proteins helps cancer cells grow and spread, and by blocking this interaction with two promising substances, they reduced cell growth and improved the effectiveness of an existing drug called Trastuzumab. This is important because it opens up new ways to treat aggressive breast cancer.
Who this helps: Patients with ErbB2-positive breast cancer.
Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents.
2019
Scientific reports
Costamagna A, Rossi Sebastiano M, Natalini D, Simoni M, Valabrega G +6 more
Plain English This research focused on the interaction between two proteins, ErbB2 and p130Cas, to help create new potential anticancer drugs. The study found that understanding how these proteins work together could lead to better treatments for cancer. This is important because it may improve outcomes for patients with cancers that involve these proteins.
Who this helps: Patients with certain types of cancer.
Physiological effects of high-flow oxygen in tracheostomized patients.
2019
Annals of intensive care
Natalini D, Grieco DL, Santantonio MT, Mincione L, Toni F +5 more
Plain English This study looked at how high-flow oxygen therapy affects patients who have a tracheostomy (a tube in their throat to help with breathing). Researchers tested three different flow rates (10, 30, and 50 liters per minute) and found that using 50 liters per minute improved oxygen levels by 40 mmHg, lowered the breathing rate by nearly 2 breaths per minute, and increased airway pressure. These results are important because they show that higher flow rates can significantly enhance breathing for these patients.
Who this helps: This helps patients with tracheostomies and their healthcare providers.
Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
2018
Cell communication and signaling : CCS
Camacho Leal MDP, Costamagna A, Tassone B, Saoncella S, Simoni M +7 more
Plain English This study looked at a protein called p130Cas, which is important for how skin cells stick together and grow. Researchers found that when this protein was deleted in mice, the skin cells grew too quickly and lost their ability to stick together properly. This study shows that p130Cas plays a crucial role in maintaining healthy skin, and not having it can lead to problems in how skin cells develop and function.
Who this helps: This research helps patients with skin conditions and doctors treating them.
Correction to: Conditional ablation of p130Cas/BCAR1 adaptor protein impairs epidermal homeostasis by altering cell adhesion and differentiation.
2018
Cell communication and signaling : CCS
Del Pilar Camacho Leal M, Costamagna A, Tassone B, Saoncella S, Simoni M +7 more
Plain English This paper corrects a mistake in the author list of a previous article about a protein called p130Cas/BCAR1 and its role in skin health. The researchers discovered that when this protein is removed, it disrupts how skin cells stick to each other and how they develop, which is important for maintaining healthy skin. This finding is significant because it helps us understand how skin conditions may arise when cell function is impaired.
Who this helps: This helps patients with skin disorders and doctors treating them.